325 related articles for article (PubMed ID: 26055982)
1. Preclinical assessment of potential interactions between botulinum toxin and neuromodulation for bladder micturition reflex.
Su X; Nickles A; Nelson DE
BMC Urol; 2015 Jun; 15():50. PubMed ID: 26055982
[TBL] [Abstract][Full Text] [Related]
2. Central inhibitory effect of intravesically applied botulinum toxin A in chronic spinal cord injury.
Munoz A; Somogyi GT; Boone TB; Smith CP
Neurourol Urodyn; 2011 Sep; 30(7):1376-81. PubMed ID: 21509809
[TBL] [Abstract][Full Text] [Related]
3. Intravesical instillation of botulinum toxin A: an in vivo murine study and pilot clinical trial.
Krhut J; Zvara P
Int Urol Nephrol; 2011 Jun; 43(2):337-43. PubMed ID: 20563845
[TBL] [Abstract][Full Text] [Related]
4. What is the exact working mechanism of botulinum toxin A and sacral nerve stimulation in the treatment of overactive bladder/detrusor overactivity? ICI-RS 2017.
Malde S; Fry C; Schurch B; Marcelissen T; Averbeck M; Digesu A; Sahai A
Neurourol Urodyn; 2018 Jun; 37(S4):S108-S116. PubMed ID: 30133790
[TBL] [Abstract][Full Text] [Related]
5. Botulinum toxin A modulates afferent fibers in neurogenic detrusor overactivity.
Conte A; Giannantoni A; Proietti S; Giovannozzi S; Fabbrini G; Rossi A; Porena M; Berardelli A
Eur J Neurol; 2012 May; 19(5):725-32. PubMed ID: 22212295
[TBL] [Abstract][Full Text] [Related]
6. Intradetrusor botulinum neurotoxin A (BoNT-A) injections decrease bladder fibrosis secondary to partial urethral obstruction in the male rat model.
Tinay I; Tanidir Y; Cikler E; Cetinel S; Tarcan T
Neurourol Urodyn; 2012 Apr; 31(4):564-70. PubMed ID: 22275224
[TBL] [Abstract][Full Text] [Related]
7. Mechanism of Action of Botulinum Toxin A in Treatment of Functional Urological Disorders.
Lin YH; Chiang BJ; Liao CH
Toxins (Basel); 2020 Feb; 12(2):. PubMed ID: 32085522
[TBL] [Abstract][Full Text] [Related]
8. Long-term follow-up of intravesical botulinum toxin-A injections in women with idiopathic overactive bladder symptoms.
Marcelissen TA; Rahnama'i MS; Snijkers A; Schurch B; De Vries P
World J Urol; 2017 Feb; 35(2):307-311. PubMed ID: 27272312
[TBL] [Abstract][Full Text] [Related]
9. Impairment of sensory afferents by intrathecal administration of botulinum toxin A improves neurogenic detrusor overactivity in chronic spinal cord injured rats.
Coelho A; Oliveira R; Cruz F; Cruz CD
Exp Neurol; 2016 Nov; 285(Pt B):159-166. PubMed ID: 27235935
[TBL] [Abstract][Full Text] [Related]
10. Early experimental results of using a novel delivery carrier, hyaluronan-phosphatidylethanolamine (HA-PE), which may allow simple bladder instillation of botulinum toxin A as effectively as direct detrusor muscle injection.
El Shatoury MG; DeYoung L; Turley E; Yazdani A; Dave S
J Pediatr Urol; 2018 Apr; 14(2):172.e1-172.e6. PubMed ID: 29482891
[TBL] [Abstract][Full Text] [Related]
11. Does Reduction of Number of Intradetrusor Injection Sites of aboBoNTA (Dysport®) Impact Efficacy and Safety in a Rat Model of Neurogenic Detrusor Overactivity?
Huynh Le Maux A; Pignol B; Behr-Roussel D; Blachon JL; Chabrier PE; Compagnie S; Picaut P; Bernabé J; Giuliano F; Denys P
Toxins (Basel); 2015 Dec; 7(12):5462-71. PubMed ID: 26694464
[TBL] [Abstract][Full Text] [Related]
12. Urodynamic and Immunohistochemical Evaluation of Intravesical Botulinum Toxin A Delivery Using Low Energy Shock Waves.
Chuang YC; Huang TL; Tyagi P; Huang CC
J Urol; 2016 Aug; 196(2):599-608. PubMed ID: 26724396
[TBL] [Abstract][Full Text] [Related]
13. Long-term effects of repeated intradetrusor botulinum neurotoxin A injections on detrusor function in patients with neurogenic bladder dysfunction.
Pannek J; Göcking K; Bersch U
BJU Int; 2009 Nov; 104(9):1246-50. PubMed ID: 19426192
[TBL] [Abstract][Full Text] [Related]
14. [INJECTION OF BOTULINUM TOXIN TYPE A IN THE BLADDER DETRUSOR AND SUBMUCOSA IN PATIENTS WITH OVERACTIVE BLADDER WITHOUT DETRUSOR OVERACTIVITY].
Krivoborodov GG; Tur EI; Efremov NS
Urologiia; 2015; (2):31-4. PubMed ID: 26237802
[TBL] [Abstract][Full Text] [Related]
15. Can clinical and urodynamic parameters predict the occurrence of neutralizing antibodies in therapy failure of intradetrusor onabotulinumtoxin A injections in patients with spinal cord injury?
Tiburtius C; Böthig R; Kowald B; Hirschfeld S; Thietje R
BMC Urol; 2020 Aug; 20(1):113. PubMed ID: 32741365
[TBL] [Abstract][Full Text] [Related]
16. Do we understand how botulinum toxin works and have we optimized the way it is administered to the bladder? ICI-RS 2014.
Apostolidis A; Rahnama'i MS; Fry C; Dmochowski R; Sahai A
Neurourol Urodyn; 2016 Feb; 35(2):293-8. PubMed ID: 26872570
[TBL] [Abstract][Full Text] [Related]
17. Reduction of urgency severity is associated with long-term therapeutic effect after intravesical onabotulinumtoxin A injection for idiopathic detrusor overactivity.
Kuo HC
Neurourol Urodyn; 2011 Nov; 30(8):1497-502. PubMed ID: 21717501
[TBL] [Abstract][Full Text] [Related]
18. Botulinum toxin injections in the management of non-neurogenic overactive bladders in children.
Léon P; Jolly C; Binet A; Fiquet C; Vilette C; Lefebvre F; Bouché-Pillon-Persyn MA; Poli-Mérol ML
J Pediatr Surg; 2014 Sep; 49(9):1424-8. PubMed ID: 25148752
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the impact on health-related quality of life of repeated detrusor injections of botulinum toxin in patients with idiopathic or neurogenic detrusor overactivity.
Gamé X; Khan S; Panicker JN; Kalsi V; Dalton C; Elneil S; Hamid R; Dasgupta P; Fowler CJ
BJU Int; 2011 Jun; 107(11):1786-92. PubMed ID: 21040367
[TBL] [Abstract][Full Text] [Related]
20. Repeated Botulinum-A toxin injection in the treatment of neuropathic bladder dysfunction and poor bladder compliance in children with myelomeningocele.
Horst M; Weber DM; Bodmer C; Gobet R
Neurourol Urodyn; 2011 Nov; 30(8):1546-9. PubMed ID: 21674597
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
